About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

LOGIN


Sign up to stay informed--receive email notifications for this journal

Therapeutic Hypothermia
and Temperature Management

Editor-in-Chief: W. Dalton Dietrich, III, PhD

ISSN: 2153-7658 • Published Quarterly • Online ISSN: 2153-7933

Current Volume: 4

Now Indexed in MEDLINE®

For Authors

  • Manuscript Submissions
  • NIH/HHMI Wellcome Trust Policies
  • Self-Archiving Policy
  • Open Access Policy
  • Manuscript Submissions

    Therapeutic Hypothermia and Temperature Management

    Instructions for Authors

    Editor-in-Chief:

    W. Dalton Dietrich, III, PhD
    Scientific Director, The Miami Project to Cure Paralysis
    Kinetic Concepts Distinguished Chair in Neurosurgery
    Professor of Neurological Surgery, Neurology and
      Cell Biology and Anatomy
    The Miami Project to Cure Paralysis
    University of Miami
    1095 NW 14th Terrace, Suite 2-30
    Miami, FL 33136-1060
    Telephone: (305) 243-2297
    Fax: (305) 243-3207
    Email: hbramlett@med.miami.edu

    AIMS and SCOPES:

    Therapeutic Hypothermia and Temperature Management is a peer-reviewed journal covering all aspects of hypothermia and temperature considerations relevant to this exciting field. Novel findings from translational preclinical investigations as well as clinical studies and trials will be featured. The journal publishes original articles, state-of-the-art review articles, protocols and best practices.  

    Manuscripts must be submitted online using the following URL:

    http://mc.manuscriptcentral.com/hypothermia


    Please read all the instructions to authors before submitting.

    Language must conform to acceptable English usage and syntax. The contents must be clear, accurate, coherent, and logical. In accepting or rejecting a manuscript, the editors will also consider its originality, teaching value, and validity.

    Manuscripts should not exceed approximately 4,000 words.  To facilitate a quick review of manuscripts, authors are encouraged to suggest names of five potential reviewers with complete contact information when the manuscript is submitted.

    For technical information on using Manuscript Central, contact Patricia Meravy at (914) 740-2132 or PMeravy@liebertpub.com 

    Manuscript Submission and Review

    Manuscripts should be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, except in the form of an abstract. Prior abstract publications should be described in the form of a footnote to the title.  Published manuscripts become the sole property of the Journal and will be copyrighted. By submitting a paper to the Journal, the author (or authors) agrees to each of the above conditions. In addition, the author (or authors) explicitly assigns any copyrighted ownership he/she (or they) may have in such paper to the Journal.

    Preparation of Manuscripts

    Papers must be submitted via upload in a word processing format, preferably in Microsoft Word. Please do not include artwork within the text document. Figures and tables should be supplied in separate files, be labeled clearly, and should be in TIFF or EPS formats. Please see the Illustrations section for further details on art submission.

    All copy must be double-spaced, including text, footnotes, references, legends, and tables. Text references must be supplied in sequence for all tables and figures.  The title page should carry the full paper title, followed by the authors’ names, degrees, and where the work was performed. Please indicate the corresponding author.

    An abstract should accompany every original paper. The abstract should appear on a separate page and should be at least 150 but not more than 300 words long. It should consist of factual information and not generalities (the problem investigated, the method used, the results obtained, and the conclusions reached). A brief introduction, materials and methods, results, discussion, acknowledgments, and reference sections should follow. At the conclusion of the references, the name and complete address of the reprint author should appear.

    Correspondence and brief communications are published at the discretion of the editors as space permits. They should be double-spaced, and must not exceed 500 words in length.

     References

    The references must be double-spaced and must be cited in alphabetical order (by author), not numerical order. In-text citations should be in name, date format, and in parentheses.) The author is responsible for the accuracy and completeness of the references.

    Examples:

    Journal:**

    Povlishock JT, Wei EP. Posthypothermic Rewarming Considerations following traumatic brain injury. J Neurotrauma 2009;26:333–340.

    [In-text citation sample: (Povlishock, 2009).]

    **Abbreviate journal names according to the style of Medline.

    Chapter in a Book:

    Yenari MA, Wijman CAC, Steinberg, GK Effects of Hypothermia on Cerebral Metabolism, Bloodflow, and Autoregulation.  In:  Therapuetic Hypothermia. Mayer SA, Sessler DI (eds). New York, NY: Informa Healthcare . 2004:  pp. 141-178.

                [In-text citation sample: (Yenari, 2004).]

    Book:

    Tisherman S, Sterz FH. Therapeutic Hypothermia. New YorkNY: Springer. 2005.

     [In-text citation sample: (Tisherman, 2005).]

     Statistical Analysis

    If a statistical analysis is done, an explanation of how it was performed must be stated at the end of the section preceding results. Unusual or complex methods of analysis should be referenced.

     Illustrations

     Please follow these guidelines for submitting figures:

    • Do NOT embed art files into a Word or PDF document. Figures provided in this format cannot be used for production purposes.
    • Line illustrations should be submitted at 600 dpi.
    • Halftones and color should be submitted at a minimum of 300 dpi.
    • Save as either TIFF or EPS files. JPEG files are for screen representation-quality only and will print very poorly during the printing process. To ensure proper print quality, please submit only TIFF or EPS files.
    • Color art must be saved as CYMK—not RGB. (NB: If files are submitted, the files will be converted to CYMK and some color variation will occur.)
    • Black and white art must be submitted as grayscale—not RGB.
    • Do NOT submit PowerPoint, PDF, Bitmap, or Excel figure or table files.
    • When naming your figure and table files, please label them with the main author’s last name, followed by a period (.), and then list the figure number. Ex: Smith.Fig1; Smith.Table1.

    Additional Information about Converting Figure Files:

    Converting Word or Excel files: Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:

    • All files should be scanned at 100% size
    • 300 dpi
    • Final color mode: CMYK
    • Save file as: .TIFor .EPS

    If you need directions on how to convert a PowerPoint slide to acceptable format go to: www.liebertpub.com/MEDIA/pdf/ppconvert.pdf

     

    IMPORTANT:

    Please upload individual files of all manuscript material—do NOT upload a single PDF file containing all text, figure, and table files of your paper. Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.


    Permissions

    Illustrations taken from other publications must be acknowledged by a complete credit line in the legend. The publisher’s letter of permission should be submitted to Therapeutic Hypothermia and Temperature Management.


    Disclosure Statement

    Immediately following the Acknowledgments section, include a section entitled ‘‘Author Disclosure Statement.’’ This text must be part of your actual manuscript file. In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. Please see the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals at www.icmje.org/roles_e.html for further guidance.  If no conflicts exist, the authors must state ‘‘No competing financial interests exist.’’

    INFORMED CONSENT, STUDY ETHICS APPROVAL, AND SUBJECT CONFIDENTIALITY


    Patients and Study Participants


    All manuscripts must comply with the privacy and confidentiality requirements outlined in the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals on the ICMJE website. For more information, visit www.icmje.org/roles_e.html


    When articles include reports of studies on human subjects, state in the Methods section that an appropriate institutional review board or ethics committee approved the study. Authors who do not have formal ethics review committees should follow the principles of the Declaration of Helsinki. In the Methods section, state that informed consent was obtained from subjects (specify written or verbal).


    The principal author must state that if animals were used experimentally, permission was obtained from the appropriate committee(s), and that the animals were treated humanely and the standards conformed to those of current ethical animal research practices.


    In addition, text and photographs should not reveal any identifying information unless it is essential for scientific purposes (in which case, consent should be obtained). Masking the subjects’ eyes in photographs is often insufficient to protect their identity.


    PROTECTION OF RESEARCH PARTICIPANTS*


    When reporting experiments on people, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national), or if no formal ethics committee is available, with the Helsinki Declaration as revised in 2008. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should indicate whether institutional and national standards for the care and use of laboratory animals were followed.


    *This portion of the Instructions for Authors has been quoted directly from the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals on the ICMJE website. For more information, visit www.icmje.org/roles_e.html

    Page Proofs

    An e-mail containing a link to the PDF file of the page proof is sent to the corresponding author. The proof should be read carefully and returned promptly to the publisher with the author’s approval and/or corrections.

    Reprints

    Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.
     

    The Journal is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215, Tel: (914) 740-2100; Fax: (914) 740-2101; E-mail: info@liebertpub.com; Website:  www.liebertpub.com.

     

  • NIH/HHMI Wellcome Trust Policies

    NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

  • Self-Archiving Policy

    Mary Ann Liebert, Inc. is a "blue" publisher (as defined by Sherpa), as we allow self-archiving of post-print (ie final draft post-refereeing) or publisher's version/PDF.

    In assigning Mary Ann Liebert, Inc. copyright, the author retains the right to deposit such a 'post-print' on their own website, or on their institution's intranet, or within the Institutional Repository of their institution or company of employment, on the following condition, and with the following acknowledgement:

    This is a copy of an article published in the [JOURNAL TITLE] © [year of publication] [copyright Mary Ann Liebert, Inc.]; [JOURNAL TITLE] is available online at: http://online.liebertpub.com.

    Authors may also deposit this version on his/her funder's or funder's designated repository at the funder's request or as a result of a legal obligation, provided it is not made publicly available until 12 months after official publication.

  • Open Access Policy


    Choose Liebert Open Access Option!

    Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) Option.

    Your investment guarantees:

    • Immediate, unrestricted global access in 170 countries
    • Maximum visibility for increased readers, citations, and downloads
    • Targeted email announcement highlighting your article to thousands of thought-leaders in your field
    • Rapid, rigorous peer-review and editorial attention
    • Fast Track online-ahead-of-print publication
    • Immediate upload to PubMed Central and other internationally recognized repositories*
    • Recognition on online Table of Contents with exclusive OA icon
    • Compliance with OA funding mandates with no embargo period
    • Savings on future OA article publication
    • Complimentary membership in AuthorCite®, the author services platform exclusively licensed by Mary Ann Liebert, Inc. that delivers the tools you need to maximize your professional impact.

    These valuable benefits are included with a one-time article processing charge (APC). APC charge varies based on journal, membership, and subsequent submissions.

    Contact openaccess@liebertpub.com for questions on article Open Access options. 

     *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.

     

    Is your Institution a member of the Liebert Author Advocacy Program?

    The Liebert Author Advocacy Program (LAAP) provides valuable membership benefits for OA publication to institutional and funding organizations, and supports global funding mandates.  Authors who are affiliated with LAAP member institutions receive all the valuable benefits of Liebert OA article publication, and more.

    For details, and to recommend institutional membership visit: www.authoradvocacy.com or contact laap@liebertpub.com 

     

     

     

Recommended Publications

You may be interested in the following publications:

    Journal of Neurotrauma

    Journal of Neurotrauma

    Provides advances in clinical and laboratory investigations of TBI and SCI, focuses on pathobiology of injury to the central nervous system, and presents preclinical and clinical trials from onset through long-term care.

    Brain Connectivity

    Brain Connectivity

    Provides the latest translational research discoveries in brain mapping, modeling, novel research techniques, and more in the rapidly advancing field of connectivity research at the systems and network levels.

Browse All Publications »

The new quarterly newsletter sponsored by the Global Science Center for Targeted Temperature Management
Click here to read the latest issue